Gliquidone Dispersible Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20080726
Indications:
Type 2 diabetes
Administration:
Oral, disperse in warm water before taking.
Take before meals. The dosage can be adjusted according to the individual patient's condition. The general daily dose is 15-180mg (1/2-6 tablets). A daily dose of 30mg (1 tablet) or less can be taken once before breakfast. For doses greater than this, the dose can be divided into morning and evening, or morning, noon, and evening. The initial treatment dose should start at 15-30mg (1/2-1 tablet), and the dose should be gradually increased according to blood glucose levels, increasing by 15-30mg (1/2-1 tablet) each time. If switching from other sulfonylurea drugs to this product, the same initial dose can be used, and the dose can be gradually adjusted as described above. The maximum daily dose generally does not exceed 180mg (6 tablets).
Specifications:
30mg
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.